An analysis of human microRNA and disease associations.

Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q. · 2008

Read An analysis of human microRNA and disease associations. by Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2559869.txt.

Introduction

Lu and colleagues analysed in 2008 the collected links between microRNAs and human diseases. MicroRNAs are tiny RNA molecules that tune gene activity, and reports tying them to illness were piling up without a clear overall pattern. The team hand-collected the published associations. They built a network connecting microRNAs to the diseases they are reported to disturb.

Clear patterns emerged from the network. MicroRNAs tended to carry similar evidence for similar diseases and different evidence for different ones. MicroRNAs expressed in many tissues were linked to more diseases than tissue-specific ones. More conserved microRNAs, those little changed across species, also showed distinctive disease links. Groups of microRNAs known to act together kept turning up sharing the same diseases. The authors say that pattern can point to new disease candidates.

Catalog record

CREATORLu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2559869

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

An Analysis of Human MicroRNA and Disease Associations By Ming Lu, Qipeng Zhang, Min Deng, Jing Miao, Yanhong Guo, Wei Gao, Qinghua Cui, Mark Isalan Published in: PLoS ONE DOI: 10.1371/journal.pone.0003420 ABSTRACT Abstract It has been reported that increasingly microRNAs are associated with diseases. However, the patterns among the microRNA-disease associations remain largely unclear. In this study, in order to dissect the patterns of microRNA-disease associations, we performed a comprehensive analysis to the human microRNA-disease association data, which is manually collected from publications. We built a human microRNA associated disease network. Interestingly, microRNAs tend to show similar or different dysfunctional evidences for the similar or different disease clusters, respectively. A negative correlation between the tissue-specificity of a microRNA and the number of diseases it associated was uncovered. Furthermore, we observed an association between microRNA conservation and disease. Finally, we uncovered that microRNAs associated with the same disease tend to emerge as predefined microRNA groups. These findings can not only provide help in understanding the associations between microRNAs and human diseases but also suggest a new way to identify novel disease-associated microRNAs. INTRODUCTION MicroRNAs (miRNAs) are a class of small non-coding RNAs (∼22 nt) which normally function as negative regulators of target mRNA expression at the posttranscriptional level. They bind to the 3′UTR of target mRNAs through base pairing, resulting in target mRNAs cleavage or translation inhibition[1], [2], [3]. It has also recently been demonstrated that miRNAs may function as positive regulators in some cases[4], [5]. It is estimated that 1–4% genes in the human genome are miRNAs and a single miRNA can regulate as many as 200 mRNAs[6]. There is increasing evidence suggesting that miRNAs play critical roles in many key biological processes, such as cell growth, tissue differentiation, cell proliferation, embryonic development, and apoptosis[6]. We previously found that miRNA also play important roles in cellular signaling network[7], cross-species gene expression variation[8], and co-regulation with transcription factors[9]. As such, mutation of miRNAs, dysfunction of miRNA biogenesis and dysregulation of miRNAs and their targets may result in various diseases. Currently, there have been reported ∼70 diseases are associated with miRNAs (see our database http://cmbi.bjmu.edu.cn/hmdd.). Many studies have produced a large number of miRNA-disease associations and shown that the mechanisms of miRNAs involved in diseases are very complex. In such a complex case, a comprehensive analysis of these data will do great help in understanding the associations between miRNAs and diseases. Furthermore, a large-scale analysis and integration of these miRNA-disease associations will offer a platform to dissect the patterns of the miRNA and disease associations, even though current known miRNA-disease associations are far from completeness. In this study, we reported our literature-based generation of miRNA-disease associations and the analysis of these data based on bioinformatics. RESULTS The human miRNA disease database We retrieved miRNA-disease associations from ∼100 papers and built a human miRNA-associated disease database (HMDD), which contains miRNA names, disease names, dysfunction evidences, and PubMed ID. HMDD is publicly accessible at website: http://cmbi.bjmu.edu.cn/hmdd. This database was built on November 2007 and the data at that time was used in the following analysis. The last update was made on July 2008. The miRNA-disease association data between November 2007 and July 2008 was used to validate the main results in this study. Dysfunctional evidences in the clusters of the miRNA-associated disease network A bipartite graph can be used as a network model to connect two disjoint sets of nodes [10], [11]. As shown in Supplementary Figure S1, a bipartite graph contains two sets of nodes. And nodes in the same set are not connected and edges only exist between nodes from different sets. Here, we constructed a bipartite graph consisting of two disjoint sets of nodes based on the associations between a list of miRNAs and a list of human diseases obtained from HMDD. One set contains human miRNA-associated diseases (69 diseases) and the other set contains disease-associated miRNAs (238 miRNAs). Based on the human miRNA-disease bipartite graph, we constructed the miRNA-associated disease network (MDN) by giving two diseases an edge if they share at least one common associated miRNA. The MDN network shows cluster structures (Supplementary Figure S2), in which similar diseases are clustered together. All cancers are connected together (Supplementary Figure S2), suggesting that various cancers may share similar associations at the miRNA level, in which some strong onco-miRNAs or miRNA suppressors may play key roles. For example, miR-21 is overexpressed in various cancers from almost all studies, showing a feature of strong onco-miRNAs, whereas miR-125a shows down-regulation in various cancers, suggesting that it is a miRNA suppressor. Similarly, all cardiovascular diseases are also connected together, which may result from some cardiovascular disease related miRNAs, such as miR-1 and miR-133, which play roles in almost all cardiovascular diseases in the MDN. The cancer cluster is clearly separated from the cardiovascular disease cluster (Supplementary Figure S2). These two clusters are connected with each other through only several hub diseases, such as heart failure, cardiac hypertrophy, and skeletal muscle hypertrophy. One exception is neointimal hyperplasia, a cardiovascular disease, which is predominantly connected to the cancer cluster and has only two connections to other cardiovascular diseases. Thus, it may share more common miRNA associations with cancers than with cardiovascular diseases. Diseases in the same cluster are highly interconnected; for example, each node connects to an average of 26 other cancers in the cancer cluster and 9 other cardiovascular diseases in the cardiovascular disease cluster, whereas cancers connect to only 5 cardiovascular diseases on average. Disease-associated miRNAs show various dysfunctions, such as mutation, up-regulation, deleted, and down-regulation. However, it remains unclear whether diseases sharing the same miRNAs have the same miRNA dysfunctions. Because most of the reported miRNA dysfunctions are either up-regulation or down-regulation, we curated most of the dysfunctions in the human miRNA disease database into these two groups. We assigned terms such as “deleted” and “low expressed” into the down-regulation group and terms such as “overexpressed”, “highly expressed”, and “over expression” into the up-regulation group. We next investigated the dysfunctional patterns within the same cluster as well as between different clusters. We calculated the number of the same dysfunctions (both up-regulation or both down-regulation) and the number of different dysfunctions (one shows up-regulation and the other shows down-regulation) for miRNAs that link diseases within the cancer cluster, or the cardiovascular disease cluster (intra-cluster), and between cancer and cardiovascular disease clusters (inter-cluster). Most of the shared miRNAs show the same dysfunctions in diseases in the same clusters, for example, 82% (578/706) of the disease pairs in the cancer cluster show the same dysfunctions and 77% (68/88) of the disease pairs in the cardiovascular disease cluster show the same dysfunctions (Table 1). However, only 54% (92/170) of the paired diseases between the cancer cluster and the cardiovascular disease cluster shows the same dysfunctions (Table 1). Diseases in different clusters thus show a larger fraction of different miRNA dysfunctions (P = 5.97×10−13, Fisher's Exact Test). For example, miR-195 is up regulated in all reported cardiovascular diseases and down regulated in all reported cancers. This result suggested that although different classes of diseases associated with common miRNA, the underlying association mechanisms might be different. [Table: The miRNA dysfunction pattern of diseases in the same clusters and between

Read the complete text